 This study was done to find out if the investigational medication, rituximab, could help relieve the symptoms of peripheral neuropathy such as numbness abnormal protein in the blood and weakness of the lower and upper extremities in people who have monoclonal gammopathy of undetermined significance and people with a symptomatic or smoldering Waldestrom macroglobulinemia. 